Search

Search Constraints

You searched for: Author/Creator Zaffaroni, N.

Search Results

1. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study. (January 2019)

3. EP-1190 Preliminary evaluation of salivary cytokines in patients treated with IMRT for head and neck cancer. (April 2019)

4. EP-1280 Identification of gene profiles associated to increased risk of acute toxicity in breast cancer. (April 2019)

5. MO-0381 Saliva microbiota and inflammation markers predict acute toxicity after RT for head-and-neck cancer. (May 2022)

8. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. (May 2017)

9. PD-0161 Single-patient microbiota & inflammation profiles modulate dose-response curves for acute toxicity. (May 2022)